Mucocutaneous Leishmaniasis

Also known as: Leishmaniasis, Mucocutaneous / Mucosal Leishmaniasis / Mucocutaneous infection caused by Leishmania (disorder) / Espundia / Infection by Leishmania braziliensis (disorder) / American mucocutaneous leishmaniasis (disorder) / Cutaneous, american leishmaniasis / Cutaneous leishmaniasis, American / Infection by Leishmania mexicana (disorder) / L.braziliensis / Leishmania braziliensis infection

DrugDrug NameDrug Description
DB00681Amphotericin BAn antifungal used to treat fungal infections in neutropenic patients, cryptococcal meningitis in HIV infection, fungal infections, and leishmaniasis.
DB09031MiltefosineAn antileishmanial agent used to treat leishmaniasis, a group of disease caused by parasites of the Leishmania type.
DB05630Sodium stibogluconateFor the treatment of various types of a protozoal infection called leishmaniasis, which may result from sandfly bites in tropical and temperate parts of the world. Also investigated for use/treatment...
DrugDrug NamePhaseStatusCount
DB13732Meglumine antimoniate2Completed1
DB09031Miltefosine2Completed2
DB00681Amphotericin B2 / 3Recruiting1
DB13732Meglumine antimoniate2 / 3Unknown Status1
DB09031Miltefosine2 / 3Recruiting1
DB00806Pentoxifylline2 / 3Recruiting1
DB00681Amphotericin B3Recruiting1
DB09031Miltefosine3Recruiting1
DB13047Pentavalent Antimony3Recruiting1
DB09031MiltefosineNot AvailableCompleted2
DB05630Sodium stibogluconateNot AvailableNo Longer Available1